Search for: "In re Dennis B."
Results 141 - 160
of 470
Sorted by Relevance
|
Sort by Date
17 Apr 2024, 9:07 am
by Dennis Crouch The Federal Circuit is set to consider the use of terms like “patented,” “proprietary,” and “exclusive” in commercial advertising can be actionable under § 43(a)(1)(B) of the Lanham Act when their use is not entirely accurate. [read post]
19 Sep 2022, 8:46 am
by Dennis Crouch In re Google, 22-1611 (Fed. [read post]
19 May 2022, 10:18 am
In re Katz, 687 F.2d 450 (CCPA 1982). [read post]
24 Mar 2017, 6:01 am
Consider the sample clause provided by the authors— “Company A hereby covenants not to sue Company B under any patent listed in Exhibit A for infringement upon any act by Company B of manufacture, use, sale, offer for sale, or import that occurs after the effective date of this Agreement. [read post]
13 Aug 2020, 10:21 am
§ 1400(b) and for improper joinder under 35 U.S.C. [read post]
23 Jun 2022, 9:01 am
§ 455(b)(4). [read post]
10 Feb 2022, 10:49 am
by Dennis Crouch Larry Junker v. [read post]
1 Nov 2018, 9:55 am
by Dennis Crouch GoPro, Inc. v. [read post]
28 Jun 2009, 10:23 pm
Bankruptcy Judge Dennis Montali, who wrote the BAP opinion in In re SNTL Corp. [read post]
7 Dec 2023, 7:08 am
by Dennis Crouch Since I have been writing about the pending appeal in In re Xencor, I thought I would keep readers updated on the briefing. [read post]
23 Sep 2014, 1:25 pm
by Dennis Crouch In Abbvie Inc. v. [read post]
4 Mar 2016, 12:25 pm
§ 282(b)(2)) Eligibility Challenges: Hemopet v. [read post]
1 Jan 2016, 9:00 am
by Dennis Crouch Welcome to 2016! [read post]
19 Jul 2012, 11:36 am
(See caselaw on 35 USC 102(a) & 102(b)). [read post]
12 Jan 2016, 11:39 am
§ 282(b)(2)) Claim Construction: Media Rights Technologies, Inc. v. [read post]
21 Mar 2024, 6:34 am
by Dennis Crouch In re Apple Inc., No. 24-111 (Fed. [read post]
28 Aug 2023, 10:41 am
by Dennis Crouch The Federal Circuit recently issued an important decision in In re: Cellect, LLC (Fed. [read post]
6 Feb 2009, 12:58 pm
Marion Berry (D-AR), Dennis Moore (D-KS) and Zach Wamp (R-TN), have re-introducing H.R. 573, which would prohibit the marketing of an authorized generic during the 180-day generic exclusivity period following a patent challenge. [read post]
23 Feb 2008, 4:24 am
Blake B. [read post]
22 Dec 2012, 12:23 pm
However, Steven B. [read post]
